Other Compounds

EV-021

Pre-clinical studies of EV-021 have shown protection against both E. coli (the most common cause of Travellers' diarrhoea) and against Anthrax. It is in early preclinical development

EV-009

Pre-clinical studies of EV-009 have shown protection against a range of bacterial infections, most notably Tularemia. It is in early preclinical development

EV-050

Is a potent antifungal that has shown activity against plant pathogens such as Botrytis cinerea. We are investigating its potential for the agricultural market.